Key result
Adding NOS inhibition to high-fat diet selectively drives bone marrow remodeling without worsening cardiac hypertrophy.
Why the study?
The integrated effects of combined metabolic stress and nitric oxide synthase inhibition on cardiovascular, immune, and skeletal tissues during obesity progression remain incompletely understood.
Does combined high-fat diet and NOS inhibition differentially remodel cardiovascular, immune, and skeletal compartments compared to high-fat diet alone in mice?
Does combined high-fat diet and NOS inhibition differentially remodel cardiovascular, immune, and skeletal compartments compared to high-fat diet alone in mice?
Combined metabolic stress and NOS inhibition in mice elicits tissue-specific remodeling, particularly in the bone marrow, rather than uniformly exacerbating obesity-induced cardiovascular pathology.
Indicates selective bone marrow effects under combined stressors in mice; leaves open relevance to human cardiometabolic outcomes.
Obesity-associated cardiometabolic disease is characterized by tissue-specific remodeling across cardiovascular, immune, and skeletal tissues. However, the integrated effects of combined metabolic stress and nitric oxide synthase (NOS) inhibition on these organ systems remain incompletely understood. We investigated whether long-term high-fat diet (HFD) feeding combined with NOS inhibition by L-NAME differentially remodels multiple organs during obesity progression. Male C57BL/6J mice were fed chow, HFD (60% kcal from fat), or HFD supplemented with constitutive NOS inhibition by L-NAME (0.5 g/L drinking water) for 15 weeks. HFD increased body weight, cardiac hypertrophy, myocardial fibrosis, and circulating myeloid-cell expansion compared with chow-fed controls. In contrast, L-NAME supplementation did not further increase body weight, cardiac hypertrophy, myocardial fibrosis, or collagen type I/type III ratio. Obesity-associated expansion of circulating neutrophils and inflammatory Ly6C hi monocytes was not observed in HFD + L-NAME mice, and instead, HFD + L-NAME selectively enhanced bone marrow remodeling, characterized by increased marrow adiposity and reduced trabecular bone volume. These findings demonstrate that combined HFD and NOS inhibition does not uniformly exacerbate obesity-induced pathology but instead elicits tissue-specific remodeling across organ systems. Under these experimental conditions, we highlight the bone marrow as a tissue prominently remodeled during combined metabolic stress and NOS inhibition, identifying the hematopoietic niche as a previously underappreciated target of cardiometabolic stress.
No takes yet. Share an insight, caveat, or question.
Drolet et al. (2026) studied Obesity-associated cardiometabolic disease. High-fat diet plus L-NAME vs. Normal chow diet and High-fat diet alone was evaluated on Multi-organ remodeling (cardiac hypertrophy, fibrosis, circulating myeloid cells, bone marrow adiposity and trabecular bone volume). Combined high-fat diet and NOS inhibition selectively enhanced bone marrow remodeling without further exacerbating cardiac hypertrophy or fibrosis compared to high-fat diet alone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: